Home Adverse Event(s) Causation Psych Adverse Meds Violence Locating Info SSRI Conference Meds Violence Conf. Medical Staff Publications More Info CV DH Marks 2008
 

Donald H. Marks, M.D. Ph.D.  

Extant Medical Legal Consulting, LLC

Medications Causing Violence, Suicide

I have examined many specific cases of potential medication-induced suicidal ideation, prepared case-specific and general causation expert reports, and given depositions and in-trial testimony.

I have had direct experience with my own patients, some of whom have developed medication-induced increases in agitation, aggression, suicidal and homicidal ideation.  

Publications

Marks, DH. Evaluation of Medical Causation, in Drug Injury: Liability, Analysis and Prevention, Second Edition, Chapter 10. O’Donnell JT editor. L&J Publications, 2005

Marks DH, Adineh M, Wang B, Gupta S.  Use of fMRI to Predict Psychiatric Adverse Effects of Interferon Treatment for Hepatitis C. Neuropsychiatric Disease and Treatment. 2007:3(5) 655-667.

Marks DH. Depression Leading to Suicide As An Adverse Effect of Metoclopramide. Internet Journal of Gastroenterology [peer-reviewed serial on the Internet]. 2007. Volume 5 Number 2.

Marks DH et al. Homicidal Ideation Causally Related To Therapeutic Medications, accepted 2008. submitted for publication.

Marks DH et al. MR Imaging of Drug-Induced Suicidal Ideation, 2008 submitted for publication.

Member of the Editorial Board, The International Journal of Risk & Safety in Medicine

Presentations:

5/10/02  Neuropsychiatric Effects of Accutane, Depression, Seizures, Psychosis & Suicide, Conference, Birmingham, AL.

7/10/02   Medication Errors and Drug Adverse Effects, Medical Staff Meeting, Brookwood Medical Center, Birmingham, AL.

10/4/02   Neuropsychiatric Effects of SSRI Drugs. Seizures, Psychosis & Suicide, Philadelphia, PA

2/2/04   Adverse Effects of SSRI Drugs, FDA Psychopharmacologic Drugs Advisory Committee, Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee

3/2/04   Medication Adverse Effects. Scientific Session, Medical Association of the State of Alabama. 

3/22/06   Application of fMRI to Understand Neuropsychopharmacologic Effects of Peg-Interferon alpha-2 & Their Treatment,  presentation to Dept Pharmacology, Rush Univ Med Ctr, Chicago

10/14/07   Use of Functional MR Imaging to Predict Psychiatric Adverse Effects of Therapeutic Medications, American College of Legal Medicine, Chicago.

4/18/08   MR Imaging of Drug-Induced Suicidal Ideation; poster presentation at the 2008 annual meeting of the American Association of Suicidology, Boston. MA

Organizer: Conference on Medication-Induced Violence, Chicago, October, 2009 (tentative)